We will be participating at the Medical Congress WUWHS2020
From March 8 – 12, 2020
Visit us at H5 – stand A11
Visit www.wuwhs2020.com for more info
Our novel debriding agent, DEBRICHEM®, has recently been featured in a 3 article supplement in the Journal of Wound Care. The articles provide an introduction
TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical DEBx Medical is innovating the management of chronic wounds, improving the life of millions
We are excited to announce that our latest paper, “Combining an Acidic Compound and NPWT: Debridement and Granulation in Leg and Foot Ulcers”, has recently
A new peer-reviewed paper on our novel debriding agent DEBRICHEM® was published in the October edition of the Journal of Wound Care. The article is
At the end of this week, DEBx Medical will participate in the Commonwealth and 4th Global Wound Conference at the Sunway Pyramid Convention Center in
